Improving outcomes in glomerular disease
Sign Up to like & getrecommendations! Published in 2021 at "Nature Reviews Nephrology"
DOI: 10.1038/s41581-021-00526-z
Abstract: Glucocorticoid exposure remains a major contributor to morbidity and mortality in patients with immune-mediated kidney disease. Recent clinical trials have tested novel potential therapies for these patients and showed that glucocorticoid doses can be reduced… read more here.
Keywords: renal response; response patients; class iii; mmf glucocorticoids ... See more keywords